Akso Health Group
AHG
$1.33
-$0.02-1.48%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 281.20% | -29.42% | -81.68% | -85.12% | -87.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 281.20% | -29.42% | -81.68% | -85.11% | -87.62% |
| Cost of Revenue | 301.67% | -24.93% | -80.76% | -80.88% | -81.03% |
| Gross Profit | 51.76% | -72.54% | -90.37% | -87.30% | 117.23% |
| SG&A Expenses | -56.85% | -50.44% | -43.61% | 49.89% | 491.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.56% | -42.71% | -59.73% | -43.93% | -26.87% |
| Operating Income | 58.06% | 49.39% | 39.45% | -14.94% | -118.63% |
| Income Before Tax | 63.03% | 49.21% | 30.42% | -135.41% | -688.98% |
| Income Tax Expenses | 28.10% | 33.20% | 42.05% | 89.12% | -55.39% |
| Earnings from Continuing Operations | 62.88% | 49.08% | 30.32% | -135.29% | -667.01% |
| Earnings from Discontinued Operations | -100.05% | -101.69% | -103.38% | 7.69% | 1,594.83% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 125.36% | 139.35% | 151.42% | 69.47% | -506.25% |
| Net Income | -17.06% | -129.64% | -595.60% | -77.82% | 21.01% |
| EBIT | 58.06% | 49.39% | 39.45% | -14.94% | -118.63% |
| EBITDA | 96.27% | 98.15% | -- | 35.31% | -88.18% |
| EPS Basic | 64.83% | -5.23% | -294.63% | -29.62% | 15.94% |
| Normalized Basic EPS | 89.01% | 77.81% | 62.65% | -96.85% | -873.36% |
| EPS Diluted | 62.52% | -0.06% | -200.24% | -27.88% | 7.86% |
| Normalized Diluted EPS | 89.01% | 77.81% | 62.65% | -96.85% | -873.36% |
| Average Basic Shares Outstanding | 565.83% | 336.06% | 106.30% | 58.33% | 8.27% |
| Average Diluted Shares Outstanding | 565.83% | 336.06% | 106.30% | 58.33% | 8.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |